255 related articles for article (PubMed ID: 17055061)
1. Vanadium in diabetes: 100 years from Phase 0 to Phase I.
Thompson KH; Orvig C
J Inorg Biochem; 2006 Dec; 100(12):1925-35. PubMed ID: 17055061
[TBL] [Abstract][Full Text] [Related]
2. Vanadium treatment of type 2 diabetes: a view to the future.
Thompson KH; Lichter J; LeBel C; Scaife MC; McNeill JH; Orvig C
J Inorg Biochem; 2009 Apr; 103(4):554-8. PubMed ID: 19162329
[TBL] [Abstract][Full Text] [Related]
3. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
5. The potentiality of vanadium in medicinal applications.
Rehder D
Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
[TBL] [Abstract][Full Text] [Related]
6. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
7. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
8. Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies.
Monga V; Thompson KH; Yuen VG; Sharma V; Patrick BO; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2678-88. PubMed ID: 15819553
[TBL] [Abstract][Full Text] [Related]
9. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
[TBL] [Abstract][Full Text] [Related]
10. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research.
Domingo JL; Gómez M
Food Chem Toxicol; 2016 Sep; 95():137-41. PubMed ID: 27417449
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic potential of insulin-mimetic vanadium complexes.
Sakurai H; Yasui H; Adachi Y
Expert Opin Investig Drugs; 2003 Jul; 12(7):1189-203. PubMed ID: 12831353
[TBL] [Abstract][Full Text] [Related]
12. Eligen insulin--a system for the oral delivery of insulin for diabetes.
Hoffman A; Qadri B
IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
[TBL] [Abstract][Full Text] [Related]
13. [Vanadium derivatives--a new source of antidiabetic drugs].
Dănilă G; Lupaşcu D
Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):74-7. PubMed ID: 10756929
[TBL] [Abstract][Full Text] [Related]
14. Reduction of oxidative stress induced vanadium toxicity by complexing with a flavonoid, quercetin: a pragmatic therapeutic approach for diabetes.
Shukla R; Barve V; Padhye S; Bhonde R
Biometals; 2006 Dec; 19(6):685-93. PubMed ID: 16703281
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound.
He Z; You G; Liu Q; Li N
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769364
[TBL] [Abstract][Full Text] [Related]
16. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
17. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
18. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin.
Bordbar AK; Creagh AL; Mohammadi F; Haynes CA; Orvig C
J Inorg Biochem; 2009 Apr; 103(4):643-7. PubMed ID: 19056126
[TBL] [Abstract][Full Text] [Related]
19. Vanadium (vanadyl sulfate). Monograph.
Altern Med Rev; 2009 Jun; 14(2):177-80. PubMed ID: 19594227
[No Abstract] [Full Text] [Related]
20. Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Gallwitz B
IDrugs; 2008 Dec; 11(12):906-17. PubMed ID: 19051153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]